Labs
Supplements
Log in
Register
AstraZeneca’s Farxiga is already battling it out with its SGLT2 rivals in Type 2 diabetes. But it may have a future in another field, too, if data from a new Type 1 study can expand its use.
Scan Me!
New to Writers Site?
Have You Reached this Page from Outside the NutriScape Network?
If so, you might be puzzled. The purpose of the Writers site is to provide dietitians in every niche with an opportunity to promote their independent businesses through Writing Articles within their specialty.
You Have Reached an Article Request Page: By publishing articles on NutriScape.NET, Dietitians can link to their own website or social media pages through the biography. We believe in Crowdsourcing. When RD/RDNs band together through The NutriScape Project, we can build a better future for all of us!
How to Use These Article Ideas